MATA NATHAN L. (Chief Scientific Officer) sold 9.4% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $166.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
American depositary share
Shares
−267.00
Price / share
$164.47
Trade value
$43.91K
% of position
American depositary share
Shares
−158.00
Price / share
$165.38
Trade value
$26.13K
% of position
American depositary share
Shares
−127.00
Price / share
$166.56
Trade value
$21.15K
% of position
American depositary share
Shares
−373.00
Price / share
$167.37
Trade value
$62.43K
% of position
American depositary share
Shares
−54.00
Price / share
$168.43
Trade value
$9.10K
% of position
American depositary share
Shares
−21.00
Price / share
$169.56
Trade value
$3.56K
% of position
Net shares
−1K
Net value
-$166.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/23/2026 | S · Sale | −267.00 | $164.47 | $43.91K | 2.5% | 10.67K | 10.40K |
| American depositary share Direct | 4/23/2026 | S · Sale | −158.00 | $165.38 | $26.13K | 1.5% | 10.40K | 10.24K |
| American depositary share Direct | 4/23/2026 | S · Sale | −127.00 | $166.56 | $21.15K | 1.2% | 10.24K | 10.11K |
| American depositary share Direct | 4/23/2026 | S · Sale | −373.00 | $167.37 | $62.43K | 3.7% | 10.11K | 9.74K |
| American depositary share Direct | 4/23/2026 | S · Sale | −54.00 | $168.43 | $9.10K | 0.6% | 9.74K | 9.69K |
| American depositary share Direct | 4/23/2026 | S · Sale | −21.00 | $169.56 | $3.56K | 0.2% | 9.69K | 9.67K |
| Total | −1K | -$166.28K | ||||||